Mildef Crete Inc. (TPEX:3213)

Blueprint Medicines Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,434	533.52	311.16	488.75	500.09	355.14
Short-Term Investments	-	234.77	206.1	206.1	-	255.02
Trading Asset Securities	1,601	210.5	-	20.03	120.07	120.04
Cash & Short-Term Investments	3,035	978.79	517.26	714.88	620.15	730.2
Cash Growth	224.45%	89.23%	-27.64%	15.28%	-15.07%	-6.04%
Accounts Receivable	231.45	214.76	429.52	107.86	71.73	186.47
Other Receivables	-	-	5	-	-	-
Receivables	231.45	214.76	434.53	107.86	71.73	186.47
Inventory	1,086	1,218	1,198	1,041	901.16	861.97
Other Current Assets	239.8	18.68	17.98	25.3	265.98	16.17
Total Current Assets	4,592	2,430	2,168	1,889	1,859	1,795
Property, Plant & Equipment	422.44	424.48	331.89	292.17	293.75	271.5
Long-Term Investments	81.72	1,249	865.98	1,055	724.02	160.79
Other Intangible Assets	4.37	5.72	6.46	9.42	7.77	4.11
Long-Term Deferred Tax Assets	79.37	79.01	74.11	64.86	68.01	66.49
Other Long-Term Assets	13.38	20.97	48.16	5.6	5.6	5.41
Total Assets	5,193	4,209	3,494	3,316	2,958	2,303
Accounts Payable	96.6	127.41	153.39	202.83	130.74	147.77
Accrued Expenses	-	-	-	-	116.16	114.76
Current Portion of Long-Term Debt	-	-	-	-	1.75	2.1
Current Portion of Leases	33.31	35.77	33.8	24.81	22.9	20.22
Current Income Taxes Payable	204.54	123.25	107.87	38.6	58.92	50.92
Current Unearned Revenue	152.14	163.57	237.64	246.66	263.91	222.33
Other Current Liabilities	535.39	161.63	151.36	108.89	0.39	1.26
Total Current Liabilities	1,022	611.63	684.05	621.79	594.78	559.36
Long-Term Debt	-	-	-	-	-	1.75
Long-Term Leases	37.38	45.76	42.02	25.09	28.63	4.51
Long-Term Deferred Tax Liabilities	274.18	237.63	166.83	204.12	137.06	49.27
Other Long-Term Liabilities	12.94	21.62	13.15	6.86	4.54	7.8
Total Liabilities	1,356	928.3	936.35	886.59	817.98	680.51
Common Stock	586.86	586.86	586.86	586.86	586.86	586.86
Additional Paid-In Capital	74.38	74.38	74.11	72.65	72.65	72.65
Retained Earnings	2,285	1,925	1,635	1,373	1,362	990.04
Comprehensive Income & Other	867.48	670.4	241.65	380.83	105.05	-44.94
Total Common Equity	3,814	3,257	2,537	2,413	2,126	1,605
Minority Interest	22.91	23.6	20.64	15.95	13.97	17.99
Shareholders' Equity	3,837	3,281	2,558	2,429	2,140	1,623
Total Liabilities & Equity	5,193	4,209	3,494	3,316	2,958	2,303
Total Debt	70.68	81.53	75.82	49.9	53.28	28.57
Net Cash (Debt)	2,965	897.26	441.44	664.99	566.87	701.62
Net Cash Growth	247.22%	103.26%	-33.62%	17.31%	-19.21%	-4.65%
Net Cash Per Share	49.79	15.05	7.41	11.17	9.52	11.73
Filing Date Shares Outstanding	58.81	58.69	58.69	58.69	58.69	58.69
Total Common Shares Outstanding	58.81	58.69	58.69	58.69	58.69	58.69
Working Capital	3,570	1,818	1,484	1,267	1,264	1,235
Book Value Per Share	64.86	55.50	43.23	41.12	36.23	27.34
Tangible Book Value	3,810	3,251	2,531	2,404	2,118	1,600
Tangible Book Value Per Share	64.78	55.40	43.12	40.96	36.10	27.27
Land	-	147.48	147.48	147.48	147.48	147.48
Buildings	-	76.88	75.61	72.78	72.3	70.49
Machinery	-	312.55	211.06	185.49	168.79	157.25

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.